Skip to main content
TipRanks
Go Ultimate75% OFF

CalciMedica (CALC) Stock Forecast & Price Target

319 Followers
See the Price Targets and Ratings of:

CALC Analyst Ratings

Moderate Buy
2Ratings
1Buy1Hold0Sell
Based on 2 analysts giving stock ratings to CalciMedica in the past 3 months

CALC Stock 12 Month Forecast

$9.00▲(625.81% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for CalciMedica in the last 3 months. The average price target is $9.00 with a high forecast of $9.00 and a low forecast of $9.00. The average price target represents a 625.81% change from the last price of $1.24.
Highest Price Target$9.00Average Price Target$9.00Lowest Price Target$9.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for CALC
Price TargetArticle
H.C. Wainwright―hold―Reiterated11/10/26
Guggenheim$9buy625.81%UpsideInitiated08/20/26
Oppenheimer$10buy706.45%UpsideReiterated05/15/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings
MDWDMediwound
IMUXImmunic
OVIDOvid Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CalciMedica

3 Months
Leland Gershell
Leland GershellOppenheimer
Success Rate6/15 ratings generated profit
40%
Average Return
-8.27%

Copying Leland Gershell's trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of -8.27% per trade.

1 Year
Leland Gershell
Leland GershellOppenheimer
Success Rate2/15 ratings generated profit
13%
Average Return
-42.61%

Copying Leland Gershell's trades and holding each position for 1 Year would result in 13.33% of your transactions generating a profit, with an average return of -42.61% per trade.

2 Years
Leland Gershell
Leland GershellOppenheimer
Success Rate1/15 ratings generated profit
7%
Average Return
-70.15%

Copying Leland Gershell's trades and holding each position for 2 Years would result in 6.67% of your transactions generating a profit, with an average return of -70.15% per trade.

CALC Analyst Recommendation Trends

01234Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for CALC
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy11110
Buy00000
Hold33211
Sell00000
Strong Sell00000
total44321

In the current month, CALC has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CALC average Analyst price target in the past 3 months is 9.00.

CALC Financial Forecast

$-5$-3.25$-1.5$0.25$2Q1 2026Q3 2026Q4 2026
High$-0.41
Consensus$-0.81
Low$-1.25

CALC Earnings Forecast

Next quarter’s earnings estimate for CALC is -$0.81 with a range of -$1.25 to -$0.41. The previous quarter’s EPS was -$0.24. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1$-0.5$0$0.5$1Q1 2026Q3 2026Q4 2026
High$0.00
Consensus$0.00
Low$0.00

CALC Sales Forecast

Next quarter’s sales forecast for CALC is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

CALC Stock Forecast FAQ

What is CALC’s average 12-month price target, according to analysts?
Based on analyst ratings, CalciMedica’s 12-month average price target is $9.00.
What is CALC’s upside potential, based on the analysts’ average price target?
CalciMedica has 625.81% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CALC a Buy, Sell or Hold?
CalciMedica has a consensus rating of Moderate Buy which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
What is CalciMedica’s price target?
The average price target for CalciMedica is $9.00. This is based on 2 12-month price targets, issued in the past 3 months. The highest analyst price target is $9.00, the lowest forecast is $9.00. The average price target represents a 625.81% increase from the current price of $1.24.
What do analysts say about CalciMedica?
CalciMedica’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of CALC?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.